Amoxicillin Chewable Tablets 400mg

Amoxicillin Chewable Tablets | Broad‑Spectrum Penicillin Antibiotic
  • Dosage: Amoxicillin 400mg
  • Packaging: 10 tablets/blister*10/box
  • Shelf Life: 36months 

Click to add this item to cart.

Product Description

Product NameAmoxicillin Chewable Tablets (Amoxicillin 400mg Chewable Oral Tablets)
SpecificationEach chewable tablet contains: Amoxicillin 400mg (as Amoxicillin Trihydrate)
Dosage FormChewable Tablet (for oral administration; chew thoroughly before swallowing)
Active IngredientAmoxicillin (as Amoxicillin Trihydrate)
Pharmacological ClassBeta-Lactam Antibiotic (Aminopenicillin)
Route of AdministrationOral administration (chew thoroughly before swallowing). May be taken with or without food. Taking with food may reduce gastrointestinal upset.
PackagingBlister pack (PVC-Alu) or HDPE bottle, typically 10 or 15 chewable tablets per blister pack or bottle
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Shelf Life36 months (unopened)

Product Overview

Amoxicillin Chewable Tablets is an oral antibiotic preparation containing Amoxicillin 400mg per chewable tablet. Amoxicillin is a semi-synthetic broad-spectrum aminopenicillin, belonging to the beta-lactam class of antibiotics. The chewable tablet formulation is designed for pediatric use or for patients who have difficulty swallowing conventional tablets, providing a palatable and easy-to-administer option.

Amoxicillin Chewable Tablets 400mg: What the Published Guidance Says

A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.

Before Amoxicillin Chewable Tablets 400mg is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.

  • WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe
  • Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
  • AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe

These points are quoted because they shape how Amoxicillin Chewable Tablets 400mg is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Supply & Specification Data for Amoxicillin Chewable Tablets 400mg

Product NameAmoxicillin Chewable Tablets (Amoxicillin 400mg Chewable Oral Tablets)
SpecificationEach chewable tablet contains: Amoxicillin 400mg (as Amoxicillin Trihydrate)
Dosage FormChewable Tablet (for oral administration; chew thoroughly before swallowing)
Active IngredientAmoxicillin (as Amoxicillin Trihydrate)
Pharmacological ClassBeta-Lactam Antibiotic (Aminopenicillin)
Route of AdministrationOral administration (chew thoroughly before swallowing). May be taken with or without food. Taking with food may reduce gastrointestinal upset.
StorageStore below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Therapeutic groupAntibacterials — Antibacterials
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ciprofloxacin 500mg Tablets, Amoxicillin Clavulanate 875/125mg Tablets, Amoxicillin Clavulanate 400/57mg Chewable Tablets, Azithromycin 500mg Tablets, Metronidazole Tablets 500mg, Ampicillin 500mg Capsules, Azithromycin 400mg Capsules, Clarithromycin 250mg Capsules.

Testing, Monographs & Batch Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Amoxicillin Chewable Tablets 400mg is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The batch record for this product normally includes:

  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Pack Configuration, Artwork & Shipping Documents

  • Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 15 chewable tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Dossier, Authority Filings & Tender Documentation

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.

This page describes Amoxicillin Chewable Tablets 400mg as a product of the antibacterials classified in the WHO AWaRe framework family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Buyer Questions about Amoxicillin Chewable Tablets 400mg

What pack size is available for Amoxicillin Chewable Tablets 400mg?

The reference pack is Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 15 chewable tablets per blister pack or bottle. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.

What documentation comes with a shipment of Amoxicillin Chewable Tablets 400mg?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.

Does the batch documentation for Amoxicillin Chewable Tablets 400mg support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Can you supply sterile injectable antibiotics with endotoxin data?

Yes. Injectable products are supplied with sterility and bacterial endotoxin results included on the batch certificate of analysis, alongside assay and related-substances data.

Do you supply amoxicillin + clavulanic acid in paediatric ratios?

We supply both the 400/57 mg chewable tablet and the 200/28.5 mg per 5 mL oral suspension presentations used in paediatric formularies.

Other Antibacterials Products in This Range

Browse the full Antibacterials range; all Tablets; the complete product catalogue.

Request a Quotation for Amoxicillin Chewable Tablets 400mg

Send the specification, pack size, quantity and destination market for Amoxicillin Chewable Tablets 400mg 400mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products